Factor Therapeutics Limited announces changes to the composition of its board occurring as an integral part of the impending change in company business as a result of signing the term sheet with Brain Biosciences Inc., doing business as (DBA) LONGMILE Veterinary PET Imaging ("LONGMILE") for the acquisition of products and technologies for companion animal and equine veterinary imaging. Dr. Cherrell Hirst AO will retire from the Board at the close of the 2020 Annual General Meeting, scheduled for 10.00am 30 July 2020. Dr. David Brookes will assume the role of Chairman. Dr. Brookes joined the Board of Factor Therapeutics in May 2019. He has extensive experience in the health and biotechnology industries and is currently a Non-Executive director of Anatara Ltd. and a Non-Executive Director of Tali Digital Limited.